Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas

BACKGROUND: Recent studies have reported mutations in the telomerase reverse transcriptase promoter (TERTp) in meningiomas. We sought to determine the frequency, clonality and clinical significance of telomere gene alterations in a cohort of patients with progressive/higher-grade meningiomas. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Juratli, Tareq A., Thiede, Christian, Koerner, Mara V.A., Tummala, Shilpa S., Daubner, Dirk, Shankar, Ganesh M., Williams, Erik A., Martinez-Lage, Maria, Soucek, Silke, Robel, Katja, Penson, Tristan, Krause, Mechthild, Appold, Steffen, Meinhardt, Matthias, Pinzer, Thomas, Miller, Julie J., Krex, Dietmar, Ely, Heather A., Silverman, Ian M., Christiansen, Jason, Schackert, Gabriele, Wakimoto, Hiroaki, Kirsch, Matthias, Brastianos, Priscilla K., Cahill, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752516/
https://www.ncbi.nlm.nih.gov/pubmed/29312603
http://dx.doi.org/10.18632/oncotarget.22650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752516/
https://www.ncbi.nlm.nih.gov/pubmed/29312603
http://dx.doi.org/10.18632/oncotarget.22650

Ejemplares similares